Elanco (ELAN)
Health Care · Animal health pharmaceuticals and biologics
Elanco is a global animal health company providing pharmaceuticals, vaccines, and nutrition solutions for livestock, poultry, and companion animals.
What Elanco does
Elanco Animal Health develops, manufactures, and distributes a broad portfolio of health and nutrition products for farm animals (livestock and poultry) and companion animals (pets). The company operates through both internal R&D and acquisitions to expand its product range, focusing on preventive and therapeutic solutions. Elanco serves veterinarians, farmers, distributors, and retailers globally, with products including pharmaceuticals, vaccines, feed additives, and nutritional supplements. The company is navigating significant industry headwinds including antibiotic restrictions, disease outbreaks, and competitive generic product pressures while pursuing cost efficiencies and margin improvements.
Themes: ["farm animal health and disease prevention","companion animal wellness","antibiotic alternatives and stewardship","animal agriculture sustainability","veterinary pharmaceuticals and vaccines"]
Fundamentals
- Price$24.62 as of 2026-07-09 close
- Market cap$12.3B as of 2026-07-10
- 1-year return+67.4% as of 2026-07-09 close
- Net margin-5.0% as of 2026-07-10
- Gross margin+55.1% as of 2026-07-10
- ROE-3.6% as of 2026-07-10
- Debt / equity0.61 as of 2026-07-10
- Revenue growth (YoY)+10.5% as of 2026-07-10
- Revenue CAGR (3y)+2.2% SEC XBRL
- Beta1.72 as of 2026-07-10
Key risks (from latest filing)
["Regulatory restrictions on antibiotic use in farm animals reducing demand for key products and limiting growth","Substantial indebtedness and debt covenant restrictions limiting financial flexibility and increasing borrowing costs","Heavy dependence on top products and exposure to competitive generic products that threaten pricing and market share"]
Competitors & peers
- Zoetis (ZTS)
- Boehringer Ingelheim (private)
- Ceva Santé Animale (private)
- Merck Animal Health (private)
- Dechra Pharmaceuticals (DCPH)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.